Docetaxel serum protein binding with high affinity to alpha1-acid glycoprotein

[1]  H. Sumiyoshi.  Clinical pharmacological evaluation of CPT-11 and cisplatin (CDDP) in patients with small cell lung cancer (SCLC) , 1995 .

[2]  Philip R. Cohen,et al.  The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere). , 1993, Cancer treatment reviews.

[3]  K. Bhalla,et al.  Binding of taxol to human plasma, albumin and alpha 1-acid glycoprotein. , 1993, Research communications in chemical pathology and pharmacology.

[4]  R. Bruno,et al.  Pharmacokinetics and metabolism of Taxotere (docetaxel). , 1993, Cancer surveys.

[5]  S. Urien.  MicroPharm, a software designed to analyse pharmacological data from kinetic, binding and tissue extraction expriments , 1991 .

[6]  M. Bogaert,et al.  Pharmacokinetic and pharmacodynamic consequences of altered binding of drugs to alpha 1-acid glycoprotein. , 1989, Progress in clinical and biological research.

[7]  Bogaert Mg,et al.  Pharmacokinetic and pharmacodynamic consequences of altered binding of drugs to alpha 1-acid glycoprotein. , 1989 .

[8]  S. Urien,et al.  Binding of indapamide to serum proteins and erythrocytes. , 1988, Biochemical pharmacology.

[9]  P. Routledge.  The plasma protein binding of basic drugs. , 1986, British journal of clinical pharmacology.

[10]  S. Urien,et al.  Role of alpha‐1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarin , 1986, Clinical pharmacology and therapeutics.

[11]  P. Blain,et al.  Determinants of plasma alpha 1-acid glycoprotein (AAG) concentrations in health. , 1985, British journal of clinical pharmacology.

[12]  P. Blain,et al.  Determinants ofplasmaa,-acid glycoprotein (AAG) concentrations inhealth , 1985 .

[13]  B. Sébille,et al.  The binding of drugs to blood plasma macromolecules: recent advances and therapeutic significance , 1984 .

[14]  F. Abramson.  Methadone plasma protein binding: Alterations in cancer and displacement from α1‐acid glycoprotein , 1982, Clinical pharmacology and therapeutics.

[15]  Y. Ostchega,et al.  Effects of cancer and its treatments on plasma concentration of alpha1‐acid glycoprotein and propranolol binding , 1982, Clinical pharmacology and therapeutics.

[16]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.